However, both human and mouse CLL cells express CD40 and toll-like receptor 9 (TLR9) and respond to treatment with αCD40 and CpG themselves, showing increased proliferation and modest protection from apoptosis. This evidence concerns the gene CD40 and B-cell chronic lymphocytic leukemia.